ETF Holdings Breakdown of KNSA

Stock Name	Kiniksa Pharmaceuticals Ltd
Ticker	KNSA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	BMG5269C1010

KNSA institutional holdings

The adjusted close for KNSA on 2025-11-12 was 40.58

The following institutional investment holdings of KNSA have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 25,636 USD 1,040,309 0.0% 40.58

2025-11-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 6,554 -0.3% USD 265,961 -0.3% 40.58

2025-11-12 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 51,311 USD 2,082,200 0.0% 40.58

2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 28,372 0.3% USD 1,151,336 0.3% 40.58

2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 28,372 0.3% USD 1,151,336 0.3% 40.58

Total = 140,245 USD 5,691,142
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-12	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	25,636	USD 1,040,309 0.0%	40.58
2025-11-12	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	6,554 -0.3%	USD 265,961 -0.3%	40.58
2025-11-12	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	51,311	USD 2,082,200 0.0%	40.58
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	28,372 0.3%	USD 1,151,336 0.3%	40.58
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	28,372 0.3%	USD 1,151,336 0.3%	40.58
Total =	140,245	USD 5,691,142

News associated with KNSA

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week High After Strong Earnings: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The company traded as high as $31.92 and last traded at $30.13, with a volume of 203102 shares. The stock had previously closed at $27.04. The company […] - 2025-07-31 02:25:08
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $54.00 Price Target at Jefferies Financial Group: Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Free Report) had its price target upped by Jefferies Financial Group from $45.00 to $54.00 in a report released on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock. KNSA has been the subject of several other reports. Wells Fargo & Company raised their target price […] - 2025-07-30 04:46:46
Wealth Enhancement Advisory Services LLC Makes New Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA): Wealth Enhancement Advisory Services LLC purchased a new position in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA – Free Report) in the 1st quarter, HoldingsChannel reports. The firm purchased 13,564 shares of the company’s stock, valued at approximately $301,000. Several other large investors also recently modified their holdings of KNSA. Bank of New York Mellon […] - 2025-07-09 05:07:41
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded to “Buy” at Wall Street Zen: Wall Street Zen upgraded shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Free Report) from a hold rating to a buy rating in a research report report published on Sunday. Several other equities analysts have also recently commented on KNSA. Jefferies Financial Group raised their price target on shares of Kiniksa Pharmaceuticals International from $40.00 to […] - 2025-07-07 03:22:59
Asset Management One Co. Ltd. Buys New Shares in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA): Asset Management One Co. Ltd. bought a new stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor bought 1,860 shares of the company’s stock, valued at approximately $41,000. Several other large investors have also recently bought and sold shares of the stock. GAMMA […] - 2025-07-02 04:44:57
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Trading Down 5.4% After Insider Selling: Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s share price traded down 5.4% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $28.44 and last traded at $28.60. 434,756 shares changed hands during trading, a decline of 14% from the average session volume of 508,421 shares. […] - 2025-06-13 02:19:05
26,808 Shares in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Bought by Squarepoint Ops LLC: Squarepoint Ops LLC acquired a new position in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 26,808 shares of the company’s stock, valued at approximately $530,000. Other large investors have also recently added to […] - 2025-06-04 05:04:47
Bank of America Corp DE Has $4.27 Million Stock Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Bank of America Corp DE increased its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 215,772 shares of the company’s stock after buying an additional 4,654 shares during […] - 2025-05-30 04:31:00
Lazard Asset Management LLC Buys Shares of 3,098 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Lazard Asset Management LLC acquired a new position in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,098 shares of the company’s stock, valued at approximately $61,000. Several other large investors have also recently made changes […] - 2025-05-26 04:50:58
BNP Paribas Financial Markets Sells 19,446 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): BNP Paribas Financial Markets cut its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 10.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 173,480 shares of the company’s stock after selling 19,446 shares during the period. BNP Paribas […] - 2025-05-15 05:36:54
Tower Research Capital LLC TRC Grows Stock Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Tower Research Capital LLC TRC lifted its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 117.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,483 shares of the company’s stock after buying an additional 4,575 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Kiniksa Pharmaceuticals were worth […] - 2025-05-07 05:32:54
Invesco Ltd. Sells 41,380 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Invesco Ltd. reduced its stake in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 74.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 14,108 shares of the company’s stock after selling 41,380 shares during the quarter. Invesco Ltd.’s holdings in Kiniksa Pharmaceuticals were worth $279,000 at the end of the […] - 2025-05-05 05:00:54
Wells Fargo & Company MN Has $417,000 Position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Wells Fargo & Company MN increased its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 54.7% in the fourth quarter, HoldingsChannel reports. The firm owned 21,102 shares of the company’s stock after buying an additional 7,463 shares during the period. Wells Fargo & Company MN’s holdings in Kiniksa Pharmaceuticals were worth […] - 2025-05-05 04:22:58
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Trading Up 4.9% Following Strong Earnings: Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price was up 4.9% during mid-day trading on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $27.15 and last traded at $27.15. Approximately 869,131 shares were traded during mid-day trading, an increase of 83% from the average daily […] - 2025-05-01 04:26:57
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Up After Strong Earnings: Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $21.47, but opened at $22.55. Kiniksa Pharmaceuticals shares last traded at $25.01, with a volume of 81,859 shares trading hands. The company reported $0.11 […] - 2025-05-01 02:18:54
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says: Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its price objective raised by Jefferies Financial Group from $40.00 to $45.00 in a report published on Tuesday morning,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. A number of other research firms also recently commented on KNSA. Citigroup began coverage on Kiniksa Pharmaceuticals […] - 2025-04-30 04:56:50
Legal & General Group Plc Has $816,000 Stock Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Legal & General Group Plc cut its stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 18.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 41,267 shares of the company’s stock after selling 9,064 shares during the quarter. Legal & General Group Plc’s […] - 2025-04-28 05:02:52
JPMorgan Chase & Co. Buys 277,827 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): JPMorgan Chase & Co. boosted its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 138.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 477,800 shares of the company’s stock after purchasing an additional 277,827 shares during the period. JPMorgan […] - 2025-04-15 05:08:56
Wellington Management Group LLP Buys 22,096 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Wellington Management Group LLP raised its stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 46.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 69,813 shares of the company’s stock after purchasing an additional 22,096 shares during the quarter. […] - 2025-04-14 05:27:05
Sei Investments Co. Has $834,000 Stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Sei Investments Co. trimmed its position in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 5.3% during the 4th quarter, HoldingsChannel reports. The firm owned 42,184 shares of the company’s stock after selling 2,354 shares during the quarter. Sei Investments Co.’s holdings in Kiniksa Pharmaceuticals were worth $834,000 at the end of the […] - 2025-04-09 04:28:48
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives Average Rating of “Buy” from Analysts: Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued ratings on the stock in the last […] - 2025-04-07 05:22:59
Principal Financial Group Inc. Sells 25,944 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Principal Financial Group Inc. lowered its stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 49.1% during the 4th quarter, HoldingsChannel reports. The firm owned 26,907 shares of the company’s stock after selling 25,944 shares during the period. Principal Financial Group Inc.’s holdings in Kiniksa Pharmaceuticals were worth $532,000 as of its most recent […] - 2025-03-07 06:17:04
Y Intercept Hong Kong Ltd Purchases Shares of 13,050 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA): Y Intercept Hong Kong Ltd acquired a new stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 13,050 shares of the company’s stock, valued at approximately $258,000. A number of other institutional investors also recently modified […] - 2025-03-05 09:01:16
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Bought by China Universal Asset Management Co. Ltd.: China Universal Asset Management Co. Ltd. grew its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 12.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 8,814 shares of the company’s stock after acquiring an additional 1,004 shares during the quarter. China Universal Asset […] - 2025-02-04 07:15:10

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.